Embed Size (px)
Citation preview
Mangalam Drugs and Organics Ltd. Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001. ® 91-22-22616200 / 6300 / 8787 C) 91-22-22619090 • CIN : L24230MH1972PLC116413
REF: MDOL/CS-SE/2019-20/039
To, Listing Department BSE Ltd 1st Floor, New Trade Wing, Phiroze Jeejeebhoy Towers, Dalai Street, Fort,
Mumbai — 400 001.
Scrip Code: 532637
Subject:
Ask
MANGALAM
WHO-GMP Accredited
January 27, 2020
Listing Department National Stock Exchange of India Limited "Exchange Plaza", 5th Floor, Plot No. C-1, Block G, Bandra - Kurla Complex, Bandra(E), Mumbai — 400 051
Symbol: MANGALAM
Newspaper Advertisement regarding publication of Un-Audited Financial Results
for the quarter and nine months ended December 31, 2019
Dear Sir / Madam,
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we enclosed herewith copies of newspaper advertisement published in Free
Press Journal (English daily) and Nayshakti (Marathi daily), Mumbai editions, both dated
January 25, 2020 in which Un-Audited Financial Results of the Company for the quarter and
nine months ended December 31, 2019 have been published.
The aforesaid results have been approved by the Board of Directors in their meeting held on
January 24, 2020.
Kindly take the above information on your records
Thanking You,
Yours Faithfully,
For Mangalam Drugs & Limited .0?
0 t.(
vAUMed1/41))
Geeta Karira Company Secretary & Compliance Officer
Factory : at Vapi (Gujarat) India t [email protected] e http://www.mangalamdrugs.com
Mangalam Drugs & Organics Ltd. NOSte aRegd. Office: Rupam Budding, XI Floor, 239. P. D' Mello Road. Near G.P.O.. Mumbai - 400 001. MAN GA AM
Phone: 91.22-22616200/6300/8787 • Fax: 91.22.22619090 • C114: 1.24230MH1972PLC116413 tip'
(A) EXTRACT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2019
(1 In Lacs)
Particulars
Quarter Ended
Nine Months Ended
Corresponding Quarter Ended
Year Ended
31.12.2019
(Unaudited)
31.12.2019 31.12.2018 31.03.2019
(Unaudited) (Unaudited) (Audited)
Total Income from operations 626026 19498.69 17980.21 22789.65
Net Profd/(Loss) for the period (before Tax Exceptional and /or Extraordinary items) 101.57 319.85 (202.36) (573.71)
Net Profitt(loss) for the period before Tax (after Exceptional arid/or Extraordinary items) 101.57 319.85 (202.36) (573.71)
Net Prolit/(Loss) for the period after tax (alter Exceptional and/or Extraordinary items 165.13 319.85 (202.36) (803.09)
Total Comprehensive Income for the period [Comprising Profit/(Loss) for the period (after tax) and other Comprehensive Income (after tax)] 166.00 321.85 (201.10) (801.40)
Equity Share Capital 1582.82 1582.82 1582.82 1582.82
Reserves (Excluding Revaluation Reserve) as'shown in the Balance Sheet 7992.80
Earnings Per Share (for continuing & discontinued operations) of Z 101-each)
a) Basic
b)Dauted
1.04
1.04
2.02
2.02
(1.28)
(1.28)
(5.07)
(5.07)
Note: 1) The Government of India has implemented Goods & Service Tax (GST) from 1°Jtdy, 2017 subsuming excise duty, service tax and various other indirect taxes. As per Ind-AS, the revenue for the quarter & nine months ended 310 December 2019 is reported net of GST.
2) The above is an extract of the detailed format of Unaudited Standalone Financial Results for the Quarter & Nine months ended 31° December, 2019 fled with the Stock Exchange under Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015. The full format of the Standalone Financial Results for the Quarter & Nine months ended 31° December. 2019 is available on the Stock Exchange websites & the Company's website. (www.bseindia.com and www.nselndia.com and www.mangalamdrugs.com)
For & on Behalf of the Board Mangalam Drugs & Organics Limited
GOVARDHAN M.DHOOT Place : Mumbai CHAIRMAN & MANAGING DIRECTOR Date : January 24, 2020 DIN: 01240086
freepressjournal. in Sat. 25 January 2020
FREEM2E".!* er a.er freepri‘ss journal in/c/48388340
%A
1-149/01/1 3i531/0, atei .5' RIctiftisa Imam: wait MAIL $510:05, 134, 41.40 tls. adl.:al. k.400, yak - Woo oat
49-22-221,91,2o0/1,3oo/Cice • Kati: 49-42-221,14040 • CIN:124230PAH1972PLC116413
(aT) 3ci ftrilvn 2 on tat timariff %oriel Z1' ymitieltqf WIT itfirczi aT-*-Errcrftam finftzr f*Iref
onthro (Mr iocm--1"
amminfrarift Rime finn/(a R) OR, OFWERRWW ERW, 4ctiii4v1 NAMIPM 3RIIURUI WNW)
arrannihrth an4 Aura nan/(sn11) Wagr«rt:r. MS, Qatidvl any(nr4l)
airfingann annum, arriffirm) srmnftwitt isr4m Arm amt/( 1) (onrarannai ton, ;Tanta 3ultr/f4-ar &Rump; onfko0
antindtmftiti Kap awe mann (eleficafte(il 4511:V WV (gT41) Wit Ntlat
?WM air win) wmt tit4tre TOM At (neVitany CV 0090$4 110 TIFtitti
wenn Mt a500) nRrniam Amino (mg zworume mot *g qii9mrome ctft TiFaI W. sot- Trdra)
(34. 011t51 IcI
tut* tam *ark nee fifer rile 0;11
riinkrk Ir4
39.91.1094 (ar-rhorrAfinr)
101.40
39.91.1094 mia.aoic (3r-zkantrefarn) (31-tkentrefing
cinsc.cz 5I9Sco /I
314.44 (101.30
39.03.1094 fr (ftlyiefern)
a/%4SAM
(me 3.0 9)
394.44 00/40
184.9 3 34S.44 (St3c) (403.0%)
I% .o o 31124 ( o 9.5o) 9962.43 I40.42 1441.“
(Coi,ao)
atita.40
30 imp 9.0W a.o1 (9./C) (4,00)
4) #1412/54 9 OW a.oa (9.14) (4.00)fta: ) nrafta num.) q a 2090 ar7 ilar art 31*i tiiti Mf414 3aaatlai art air* awn filar a anirroft (anima) airranrinfl 401
a*. am, \m.it-scin walk 9 ratio Rol% tat thiciour two. alit RV mbarTrcIF3<ttar a MI 4W (41/4 .'14) iWT 45-1Ff
ninairant am* and. a) rata nate si 041 (f*tin alas ft-rraalm **melte) tig-aniqr. Qoitt ern Ainita-eft 33 3iifi t'cftc atrt a red arise
award 040WW. al fatiai 2094 daft finnt a rithsinfttai artereitzn ankrinntlfInt Tarn Rita qiiegfen WiWRI 3aRt 3111. 35 ftrlaR a oi4 nail alalkwa fatal a WW.40101 altaaffithaall Watitiftd wRia Rita Atantfur i&aUf 3fititti Wail(
crairellififi *vile (www.bseindia.com a www.nseindia.com anti% www.mangalamdrugs.com) umatz ant
vnim : tat R rim : aW wr4iTft, 4*40
ownoqf
riRaq VA alas ainfkint Difirts aiRmr
*arta knr. ylr WWZIO Zr WTIW2Tha4;ag WWWW
DIN: 0:042Wo0C%
Sat, 25 January 2020 epaper.freepressjournal.in/c/48388413
